DMAC
Price
$7.30
Change
+$0.40 (+5.80%)
Updated
Nov 19 closing price
Capitalization
380.69M
131 days until earnings call
Intraday BUY SELL Signals
WHWK
Price
$2.09
Change
-$0.05 (-2.34%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
98.03M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DMAC vs WHWK

Header iconDMAC vs WHWK Comparison
Open Charts DMAC vs WHWKBanner chart's image
DiaMedica Therapeutics
Price$7.30
Change+$0.40 (+5.80%)
Volume$811.24K
Capitalization380.69M
Whitehawk Therapeutics
Price$2.09
Change-$0.05 (-2.34%)
Volume$2.93K
Capitalization98.03M
DMAC vs WHWK Comparison Chart in %
DMAC
Daily Signal:
Gain/Loss:
WHWK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DMAC vs. WHWK commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a Hold and WHWK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (DMAC: $7.31 vs. WHWK: $2.08)
Brand notoriety: DMAC and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 236% vs. WHWK: 8%
Market capitalization -- DMAC: $380.69M vs. WHWK: $98.03M
DMAC [@Biotechnology] is valued at $380.69M. WHWK’s [@Biotechnology] market capitalization is $98.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than DMAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 6 TA indicator(s) are bullish while WHWK’s TA Score has 5 bullish TA indicator(s).

  • DMAC’s TA Score: 6 bullish, 4 bearish.
  • WHWK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DMAC is a better buy in the short-term than WHWK.

Price Growth

DMAC (@Biotechnology) experienced а +15.85% price change this week, while WHWK (@Biotechnology) price change was -6.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

DMAC is expected to report earnings on Mar 31, 2026.

WHWK is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DMAC($381M) has a higher market cap than WHWK($98M). DMAC YTD gains are higher at: 34.622 vs. WHWK (-34.073). WHWK has higher annual earnings (EBITDA): -10.21M vs. DMAC (-31.42M). WHWK has more cash in the bank: 177M vs. DMAC (30M). WHWK has less debt than DMAC: WHWK (0) vs DMAC (292K). WHWK has higher revenues than DMAC: WHWK (21.6M) vs DMAC (0).
DMACWHWKDMAC / WHWK
Capitalization381M98M389%
EBITDA-31.42M-10.21M308%
Gain YTD34.622-34.073-102%
P/E RatioN/A11.67-
Revenue021.6M-
Total Cash30M177M17%
Total Debt292K0-
FUNDAMENTALS RATINGS
DMAC vs WHWK: Fundamental Ratings
DMAC
WHWK
OUTLOOK RATING
1..100
2282
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
7596
SMR RATING
1..100
9690
PRICE GROWTH RATING
1..100
3948
P/E GROWTH RATING
1..100
10036
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DMAC's Valuation (54) in the Biotechnology industry is in the same range as WHWK (56) in the Pharmaceuticals Major industry. This means that DMAC’s stock grew similarly to WHWK’s over the last 12 months.

DMAC's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as WHWK (96) in the Pharmaceuticals Major industry. This means that DMAC’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's SMR Rating (90) in the Pharmaceuticals Major industry is in the same range as DMAC (96) in the Biotechnology industry. This means that WHWK’s stock grew similarly to DMAC’s over the last 12 months.

DMAC's Price Growth Rating (39) in the Biotechnology industry is in the same range as WHWK (48) in the Pharmaceuticals Major industry. This means that DMAC’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's P/E Growth Rating (36) in the Pharmaceuticals Major industry is somewhat better than the same rating for DMAC (100) in the Biotechnology industry. This means that WHWK’s stock grew somewhat faster than DMAC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DMACWHWK
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DMAC
Daily Signal:
Gain/Loss:
WHWK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LDGYY18.85N/A
N/A
Landis Gyr Group AG
SIEVF191.00N/A
N/A
D IETEREN GROUP NV
SNHO0.22N/A
N/A
SHONGHOYA INTL GROUP INC.
TCEHY79.55-0.61
-0.76%
Tencent Holding Ltd.
GSHRF0.36N/A
-1.35%
GOLD X2 MINING INC.

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
-2.80%
AXON - WHWK
44%
Loosely correlated
-0.50%
DMAC - WHWK
41%
Loosely correlated
+5.94%
AMRN - WHWK
37%
Loosely correlated
+1.08%
ARRY - WHWK
36%
Loosely correlated
-2.47%
SNDX - WHWK
34%
Loosely correlated
-2.22%
More